13.16 USD
↘ 1.16 (8.10%)AT CLOSE (11:59 AM EDT)
Vor Biopharma Inc. Common Stock
VORNASDAQ • USD
13.44
↗ 0.28 (2.13%)
POST MARKET (AS OF 07:32 PM EDT)
Post Market
AS OF 07:32 PM EDT
13.44
↗ 0.28 (2.13%)
Market: CLOSED
Open?$14.28
High?$14.45
Low?$12.90
Prev. Close?$14.32
Volume?597.3K
Avg. Volume?798.1K
VWAP?$13.49
Rel. Volume?0.75x
Bid / Ask
Bid?$13.10 × 200
Ask?$13.62 × 500
Spread?$0.52
Midpoint?$13.36
Valuation & Ratios
Market Cap?713.1M
Shares Out?54.2M
Float?29.2M
Float %?70.3%
P/E Ratio?N/A
P/B Ratio?-4.74
EPS?-$16.30
Dividend?0.00%
Ex-Dividend?N/A
Shares of Vor Biopharma Inc. Common Stock (VOR) are trading at $13.16. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (587.1%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
Themes
Employees
76
Market Cap
713.1M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-02-05
Address
500 BOYLSTON STREET
BOSTON, MA 02116
Phone: 617-655-6580
BOSTON, MA 02116
Phone: 617-655-6580
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?36
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.43Distress
Confidence?56%Low
Short InterestHigh
Short % of Float?15.74%High
Short Interest?4.6M
Days to Cover?5.3
Free Float29.2M
Avg Daily Volume873.9K
Settlement Date2026-05-15
Financial Health
Current Ratio?31.15Strong
Quick Ratio?31.15Strong
Cash Ratio?10.57Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-4.74CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.5CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?587.1%STRONG▾
Peers50
S&P97
ROA?-174.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-150651000
Enterprise Value?$543.2M
Fundamentals ratios updated end of day